Fakhry, M.M.; Mattar, A.A.; Alsulaimany, M.; Al-Olayan, E.M.; Al-Rashood, S.T.; Abdel-Aziz, H.A.
New Thiazolyl-Pyrazoline Derivatives as Potential Dual EGFR/HER2 Inhibitors: Design, Synthesis, Anticancer Activity Evaluation and In Silico Study. Molecules 2023, 28, 7455.
https://doi.org/10.3390/molecules28217455
AMA Style
Fakhry MM, Mattar AA, Alsulaimany M, Al-Olayan EM, Al-Rashood ST, Abdel-Aziz HA.
New Thiazolyl-Pyrazoline Derivatives as Potential Dual EGFR/HER2 Inhibitors: Design, Synthesis, Anticancer Activity Evaluation and In Silico Study. Molecules. 2023; 28(21):7455.
https://doi.org/10.3390/molecules28217455
Chicago/Turabian Style
Fakhry, Mariam M., Amr A. Mattar, Marwa Alsulaimany, Ebtesam M. Al-Olayan, Sara T. Al-Rashood, and Hatem A. Abdel-Aziz.
2023. "New Thiazolyl-Pyrazoline Derivatives as Potential Dual EGFR/HER2 Inhibitors: Design, Synthesis, Anticancer Activity Evaluation and In Silico Study" Molecules 28, no. 21: 7455.
https://doi.org/10.3390/molecules28217455
APA Style
Fakhry, M. M., Mattar, A. A., Alsulaimany, M., Al-Olayan, E. M., Al-Rashood, S. T., & Abdel-Aziz, H. A.
(2023). New Thiazolyl-Pyrazoline Derivatives as Potential Dual EGFR/HER2 Inhibitors: Design, Synthesis, Anticancer Activity Evaluation and In Silico Study. Molecules, 28(21), 7455.
https://doi.org/10.3390/molecules28217455
